Lopurin and Hyperkalemia - a phase IV clinical study of FDA data
Summary:
Hyperkalemia is found among people who take Lopurin, especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months.
The phase IV clinical study analyzes which people take Lopurin and have Hyperkalemia. It is created by eHealthMe based on reports of 164,084 people who have side effects when taking Lopurin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
164,084 people reported to have side effects when taking Lopurin.
Among them, 3,021 people (1.84%) have Hyperkalemia.
What is Lopurin?
Lopurin has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 166,598 Lopurin users for its effectiveness, alternative drugs and more.
What is Hyperkalemia?
Hyperkalemia (damage to or disease of the kidney) is found to be associated with 3,274 drugs and 2,849 conditions by eHealthMe.
Number of Lopurin and Hyperkalemia reports submitted per year:

Time on Lopurin when people have Hyperkalemia *:
Gender of people who have Hyperkalemia when taking Lopurin*:
Age of people who have Hyperkalemia when taking Lopurin *:
Common drugs people take besides Lopurin *:
Common side effects people have besides Hyperkalemia *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Lopurin and have Hyperkalemia?
Check whether Hyperkalemia is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
How severe was Hyperkalemia and when was it recovered:
Expand to all the drugs that have ingredients of allopurinol:
- Hyperkalemia and drugs with ingredients of allopurinol (3,081 reports)
Alternative drugs to, pros and cons of Lopurin:
- Lopurin (166,598 reports)
Common Lopurin side effects:
- Diarrhea: 9,704 reports
- Fatigue (feeling of tiredness): 9,573 reports
- Breathing difficulty: 9,370 reports
- Weakness: 8,160 reports
- Fever: 8,051 reports
- Pneumonia: 7,437 reports
- Thrombocytopenia (decrease of platelets in blood): 7,369 reports
Browse all side effects of Lopurin:
a b c d e f g h i j k l m n o p q r s t u v w x y zHyperkalemia treatments and more:
- Hyperkalemia (70,850 reports)
COVID vaccines that are related to Hyperkalemia:
- Hyperkalemia in Moderna COVID Vaccine
- Hyperkalemia in Pfizer BioNTech Covid Vaccine
- Hyperkalemia in Johnson and Johnson Covid Vaccine
Common drugs associated with Hyperkalemia:
- Furosemide: 6,036 reports
- Metformin: 5,328 reports
- Spironolactone: 4,217 reports
- Aspirin: 4,200 reports
- Lasix: 3,990 reports
- Lisinopril: 3,919 reports
- Allopurinol: 3,021 reports
- Lopurin: 3,021 reports
- Amlodipine: 2,901 reports
- Aldactone: 2,693 reports
All the drugs that are associated with Hyperkalemia:
- Hyperkalemia (3,274 drugs)
Common conditions associated with Hyperkalemia:
- High blood pressure: 9,766 reports
- Type 2 diabetes: 2,927 reports
- Diabetes: 2,483 reports
- Atrial fibrillation/flutter: 1,928 reports
- Pain: 1,908 reports
All the conditions that are associated with Hyperkalemia:
- Hyperkalemia (2,849 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on allopurinol (the active ingredients of Lopurin) and Lopurin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Solifenacin Succinate and Glatiramer Acetate drug interaction - a second ago
- Xeljanz and Inflammation - a second ago
- Adipex-P and Ergocalciferol drug interaction - 5 seconds ago
- Eliquis and Bifidum drug interaction - 11 seconds ago
- Prednisone and Neuralgia - 13 seconds ago
- Aspirin and Fatigue - 19 seconds ago
- Ditropan vs. Tamsulosin Hydrochloride - 22 seconds ago
- Prednisone and Emphysema - 39 seconds ago
- Arimidex and Glyburide And Metformin Hydrochloride drug interaction - 40 seconds ago
- Doptelet and Drowsiness - 42 seconds ago